Detection of Liver Metastases from Adenocarcinoma of the Colon and Pancreas: Comparison of Mangafodipir TrisodiumEnhanced Liver MRI and Whole-Body FDG PET
Dushyant V. Sahani,
Sanjeeva P. Kalva,
Alan J. Fischman,
Rajagopal Kadavigere,
Michael Blake,
Peter F. Hahn and
Sanjay Saini
Department of Radiology, Massachusetts General Hospital, 55 Fruit St.,
Boston, MA 02114-2696.
Fig. 1A55-year-old man with colon cancer metastases to liver.
Whole-body FDG PET coronal maximum-intensity-projection image shows focal area
of increased FDG uptake in right lobe of liver (arrow).
Fig. 1B55-year-old man with colon cancer metastases to liver.
Mangafodipir trisodium-enhanced axial T1-weighted fat-saturated image shows
cluster of three focal lesions (arrow) in dome of liver that
correlated with area of increased FDG activity seen in A.
Fig. 1C55-year-old man with colon cancer metastases to liver.
Mangafodipir trisodium-enhanced axial T1-weighted fat-saturated image shows
additional small (9 mm) lesion (arrow) in anterosuperior segment.
Fig. 2A50-year-old man with colon cancer. Whole-body FDG PET coronal
oblique maximum-intensity-projection image shows focal increased uptake in
right lobe of liver (arrow).
Fig. 2B50-year-old man with colon cancer. Axial mangafodipir
trisodium-enhanced T1-weighted fat-saturated image shows lesion
(arrow) in posterosuperior segment of right lobe.